CXCL9 and CXCL11 Levels in Patients With Autoimmune Thyroiditis and Habitual Abortions | NCT01644318 | Trialant
Unknown statusObservationalUpdated Jul 19, 2012
CXCL9 and CXCL11 Levels in Patients With Autoimmune Thyroiditis and Habitual Abortions
ClinicalTrials.gov ID
NCT01644318
Lead Sponsor
Ankara Education and Research HospitalOTHER_GOV
Overall Status
Unknown status
Study Type
Observational
Last Update Posted
Jul 19, 2012Estimated
Brief Summary
The purpose of this study is to measure serum CXCL9 and CXCL11 levels in patients with autoimmune thyroiditis and habitual abortions
Habitual Abortion
No interventions
There are no interventions for this study.
Ages Eligible for Study
Adult (18-64)
Sexes Eligible for Study
Female
Accepts Healthy Volunteers
No data available
Eligibility Criteria
Inclusion Criteria:
non-pregnant women with euthyroid autoimmune thyroiditis and a history of first trimester recurrent spontaneous abortions
Exclusion Criteria:
1) presence of acute or chronic systemic diseases; 2) other autoimmune diseases; 3) pregnancy and lactation over the previous 6 months; 4) evidence of infectious diseases in the last 3 months; 5) treatment with drugs known to interfere with cytokine release, such as corticosteroids, immunosuppressors, or nonsteroidal antiinflammatory drugs, amiodarone, and lithium; 6) clinical history of hyperthyroidism and/or the presence of anti-TSH receptor antibodies.